1. 5PSQ-157 Expenditure and consumption descriptive analysis: rituximab originator versus biosimilar in an Italian district. (14th March 2021) Authors: Parola, BMA; Alemanno, S; Capilli, M; Colasanto, I; Fiorentino, D; Marcato, M; Pestrin, L; Strobino, S; Varese, A; Viglione, E; Brunitto, G Journal: European journal of hospital pharmacy Issue: Volume 28(2021)Supplement 1 Page Start: A133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. (10th October 2018) Authors: Marandino, L; La Salvia, A; Sonetto, C; De Luca, E; Pignataro, D; Zichi, C; Di Stefano, R F; Ghisoni, E; Lombardi, P; Mariniello, A; Reale, M L; Trevisi, E; Leone, G; Muratori, L; Marcato, M; Bironzo, P; Novello, S; Aglietta, M; Scagliotti, G V; Perrone, F Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗